| OHSU # 1803 | Split-luciferase complementation to measure soluble epoxide hydrolase dimerization | Jonathan Nelson, Nabil Alkayed, Xiangshu Xiao |
| OHSU # 1658-E | pLXSN human KIT V654A + D816Y | Michael Heinrich |
| OHSU # 1658-D | pLXSN human KIT V654A + D816F | Michael Heinrich |
| OHSU # 1658-C | pLXSN human KIT D816F retrovirally transduced BaF3 cells | Michael Heinrich |
| OHSU # 1658-B | pLXSN human KIT D816Y retrovirally transduced BaF3 cells | Michael Heinrich |
| OHSU # 1658-A | M5gNeo human KIT D816V retrovirally transduced BaF3 cells | Michael Heinrich |
| OHSU # 1417 | Single Particle Quantum Dot Imaging Achieves Ultrasensitive Detection Capabilities for Western Immunoblot Analysis | Tania Vu, Brian Long, Benjamin Scholl |
| OHSU # 1390 | Profiling circulating fragments of fibrillin-1, fibrillin-2, and fibulin-4 as biomarkers for disease | Lynn Sakai, Eric Carlson, Noe Charbonneau, Susan Hayflick |
| OHSU # 1289 | BB19 Cell Line | Jay Nelson, Ashlee Moses |
| OHSU # 1275 | Computational Model Analysis of I/V Relation Currents of Vascular Cells | Zhi-Gen Jiang, Fangyi Chen, Yu-Qin (Jean) Yang, Ketao Ma |
| OHSU # 1224 | Murine Model System for Human Cytomegalovirus Latency and Pathogenesis | Jay Nelson, M. Shane Smith, J. Victor Garcia-Martinez, William Fleming, Florence Othieno, Alexis Bailey, Felicia Goodrum |
| OHSU # 1221-S | Human cytomegalovirus (HCMV) clinical isolate strain: Watkins | Jay Nelson |
| OHSU # 1221-R | Human cytomegalovirus (HCMV) clinical isolate strain: Simpson | Jay Nelson |
| OHSU # 1221-Q | Human cytomegalovirus (HCMV) clinical isolate strain: Schmoe | Jay Nelson |
| OHSU # 1221-P | Human cytomegalovirus (HCMV) clinical isolate strain: Salvo | Jay Nelson |
| OHSU # 1221-O | Human cytomegalovirus (HCMV) clinical isolate strain: Powers | Jay Nelson |
| OHSU # 1221-N | Human cytomegalovirus (HCMV) clinical isolate strain: Phoebe | Jay Nelson |
| OHSU # 1221-M | Human cytomegalovirus (HCMV) clinical isolate strain: New Rock | Jay Nelson |
| OHSU # 1221-L | Human cytomegalovirus (HCMV) clinical isolate strain: Martinez | Jay Nelson |
| OHSU # 1221-K | Human cytomegalovirus (HCMV) clinical isolate strain: Lysistrata | Jay Nelson |
| OHSU # 1221-J | Human cytomegalovirus (HCMV) clinical isolate strain: Lacey | Jay Nelson |
| OHSU # 1221-I | Human cytomegalovirus (HCMV) clinical isolate strain: Keone | Jay Nelson |
| OHSU # 1221-H | Human cytomegalovirus (HCMV) clinical isolate strain: Harris | Jay Nelson |
| OHSU # 1221-G | Human cytomegalovirus (HCMV) clinical isolate strain: Gruden | Jay Nelson |
| OHSU # 1221-F | Human cytomegalovirus (HCMV) clinical isolate strain: Gerry | Jay Nelson |
| OHSU # 1221-E | Human cytomegalovirus (HCMV) clinical isolate strain: Edding | Jay Nelson |
| OHSU # 1221-D | Human cytomegalovirus (HCMV) clinical isolate strain: Dement | Jay Nelson |
| OHSU # 1221-C | Human cytomegalovirus (HCMV) clinical isolate strain: Davis | Jay Nelson |
| OHSU # 1221-B | Human cytomegalovirus (HCMV) clinical isolate strain: Brown | Jay Nelson |
| OHSU # 1221-A | Human cytomegalovirus (HCMV) clinical isolate strain: Adinis | Jay Nelson |
| OHSU # 1221 | Human cytomegalovirus (HCMV) clinical isolate strains | Jay Nelson |
| OHSU # 1219 | Non-Human Primate Model for Stroke | Mary Stenzel-Poore, G. Alexander West, Roger Simon |
| OHSU # 1187 | SK3 Floxed Allele Mice (SK3 Null Mice) | John Adelman, Chris Bond, James Maylie |
| OHSU # 1185 | Balance Evaluation Systems Test: BESTest | Fay Horak |
| OHSU # 1124-B | Yeast strain expressing human VDAC2 | Michael Forte, Elizabeth Blachly-Dyson |
| OHSU # 1124-A | Yeast strain expressing human VDAC1 | Michael Forte, Elizabeth Blachly-Dyson |
| OHSU # 1056 | Cell Free Screening Assay | Maureen Hoatlin, Alexandra Sobeck, Stacie Stone |
| OHSU # 0959 | CyP-D Knock-Out Mice | Michael Forte, Paolo Bernardi, Emy Basso |
| OHSU # 0891 B | Small-Conductance CA2+-Activated Potassium Channel 2 (SK2) Transgenic Mice | John Adelman, Chris Bond, James Maylie |
| OHSU # 0891 | Small-Conductance CA2+-Activated Potassium Channel 1 (SK1) Transgenic Mice | John Adelman, Chris Bond, James Maylie |
| OHSU # 0726 | Antiviral Drug Discovery for AIDS: The HIV-1 Vif Protein | David Kabat, Mariana Marin, Susan Kozak, Kristine Rose |
| OHSU # 0618 | Methods of selecting T cell receptor V peptides for therapeutic use | Arthur Vandenbark |
| OHSU # 0557 | Novel Mammalian Catecholmine Receptor Genes and Uses | Mark Sonders, James Bunzow, David Grandy |
| OHSU # 0515 | Small-Conductance Ca2+-Activated Potassium Channel 3 (SK3) transgenic mice | Chris Bond, John Adelman |
| OHSU # 0502 | Melanocortin-3 Receptor Knockout Mice | Roger Cone, Andrew Butler, Robert Kesterson |
| OHSU # 0500 | A Japanese Macaque Virus Model for Multiple Sclerosis | Robert Searles, Scott Wong, Michael Axthelm |
| OHSU # 0463-C | H9 cell clone H9.42 susceptible to HIV isolates | David Kabat |
| OHSU # 0463-B | H9 cell clone H9.38 susceptible to HIV isolates | David Kabat |
| OHSU # 0463 | H9 cell clones susceptible to HIV isolates | David Kabat |
| OHSU # 0422 | U87MG Cell Lines Expressing CD4, CD4 and CCR5, or CD4 and CXCR4 | David Kabat, Emily Platt |
| OHSU # 0418 | Mouse PMS-2 (-/-) Embryonic Cell Line | R. Michael Liskay, C. Eric Bronner, Sean Baker |
| OHSU # 0417 | Pms-2 Knockout Mouse | R. Michael Liskay, C. Eric Bronner, Sean Baker, Yale Univ./Flavell |
| OHSU # 0416 | Mouse Mlh-1 (-/-) Embryonic Cell Line | R. Michael Liskay, Sean Baker, Baylor Col. Med. |
| OHSU # 0405 | D2 Dopamine Receptor Knock-Out Mice | Malcolm Low, David Grandy, Marcelo Rubinstein, Michele Kelly |
| OHSU # 0392-G | Transformed HeLa Cell Line Clone RC.49 | David Kabat |
| OHSU # 0392-F | Transformed HeLa Cell Line Clone RC.55 | David Kabat |
| OHSU # 0392-E | Transformed HeLa Cell Line Clone RC.30 | David Kabat |
| OHSU # 0392-D | Transformed HeLa Cell Line Clone HI-R | David Kabat |
| OHSU # 0392-C | Transformed HeLa Cell Line Clone H1-J(C.10) | David Kabat |
| OHSU # 0392-B | Transformed HeLa Cell Line Clone H1-J(C.53) | David Kabat |
| OHSU # 0392-A | Transformed HeLa Cell Line Clone H1-J(C.37) | David Kabat |
| OHSU # 0387-B | MC5-R Knockout mice | Malcolm Low, Wenbiao Chen, Roger Cone |
| OHSU # 0387-A | Regulation of Exocrine Gland Function by Modulation of Melanocortin-5 Receptor (MC5-R) Activity | Roger Cone, Wenbiao Chen, Malcolm Low |
| OHSU # 0380 | Putative Mammalian Catecholamine Receptor (p-Tyramine-R)(TAR) | David Grandy, James Bunzow |
| OHSU # 0379 | D4 Dopamine Receptor Knock-Out Mice | Malcolm Low, David Grandy, Marcelo Rubinstein |
| OHSU # 0367 | Methods and Reagents for Using Mammalian Melanocortin Receptor Agonists and Antagonists to Modulate Feeding Behavior in Animals (MC3&4) | Roger Cone, Wei Fan, Bruce Boston, Robert Kesterson, Dongsi Lu, Wenbiao Chen |
| OHSU # 0264 | Mammalian Melanocortin Receptors and Uses (MC3) | Roger Cone, Linda Roselli-Rehfuss, Kathleen Mountjoy, Linda Robbins |
| OHSU # 0250 | A Novel Human Dopamine Receptor and its Uses (D4 subtypes - D4.2,4.4,4.7) | Olivier Civelli, Hubert Henri-Marie Van Tol, James Bunzow, David Grandy |
| OHSU # 0245 | Mammalian Adrenocorticotropic Hormone Receptors and Uses (MC2) | Roger Cone, Kathleen Mountjoy |
| OHSU # 0244 | Mammalian Melanocyte Stimulating Hormone Receptors and Uses (MC1) | Roger Cone, Kathleen Mountjoy, Linda Roselli-Rehfuss |
| OHSU # 0223 | A Novel Adenosine Receptor (A3) and Uses | Olivier Civelli, Qun Zhou, Gary Stiles |
| OHSU # 0199 | D4 Cloning of a Human Dopamine Receptor | Olivier Civelli, Hubert Henri-Marie Van Tol, David Grandy, James Bunzow |
| OHSU # 0165 | D2 Dopamine Receptor and Genes and Associated United States Patents | Olivier Civelli, James Bunzow, David Grandy, Curtis Machida |
| OHSU # 0134 | D2 Dopamine Receptor and Genes and Associated International Patents | Olivier Civelli, James Bunzow, David Grandy, Curtis Machida |
